Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.
Daines, Bryan; Madigan, Lauren M; Vitale, Patricia A; Khalighi, Mazdak; Innes, Matthew.
Dermatol Online J ; 28(4)2022 Aug 15.
Article in English | MEDLINE | ID: covidwho-2067003

ABSTRACT

The rapid development and implementation of COVID-19 vaccines throughout the global population has given rise to unique, rare, adverse skin reactions. This case report describes an elderly man with new-onset bullous pemphigoid following the second dose of the Pfizer-BioNTech (mRNA) COVID-19 vaccine.


Subject(s)
COVID-19 Vaccines , COVID-19 , Exanthema , Pemphigoid, Bullous , Aged , Humans , Male , COVID-19 Vaccines/adverse effects , Pemphigoid, Bullous/etiology , RNA, Messenger , Vaccination/adverse effects
2.
Evaluating risk of bullous pemphigoid after mRNA COVID-19 vaccination.
Birabaharan, Morgan; Kaelber, David C; Orme, Charisse M; Paravar, Taraneh; Karris, Maile Y.
Br J Dermatol ; 187(2): 271-273, 2022 08.
Article in English | MEDLINE | ID: covidwho-1741340

Subject(s)
COVID-19 Vaccines , COVID-19 , Pemphigoid, Bullous , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Pemphigoid, Bullous/etiology , RNA, Messenger
3.
Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review.
Pauluzzi, M; Stinco, G; Errichetti, E.
J Eur Acad Dermatol Venereol ; 36(4): e257-e259, 2022 Apr.
Article in English | MEDLINE | ID: covidwho-1583505

Subject(s)
COVID-19 , Pemphigoid, Bullous , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Humans , Male , Pemphigoid, Bullous/etiology , Vaccines, Synthetic , mRNA Vaccines
4.
Bullous pemphigoid after SARS-CoV-2 vaccination: spike-protein-directed immunofluorescence confocal microscopy and T-cell-receptor studies.
Gambichler, T; Hamdani, N; Budde, H; Sieme, M; Skrygan, M; Scholl, L; Dickel, H; Behle, B; Ganjuur, N; Scheel, C; Abu Rached, N; Ocker, L; Stranzenbach, R; Doerler, M; Pfeiffer, L; Becker, J C.
Br J Dermatol ; 186(4): 728-731, 2022 04.
Article in English | MEDLINE | ID: covidwho-1511286

Subject(s)
COVID-19 , Pemphigoid, Bullous , COVID-19/prevention & control , COVID-19 Vaccines/adverse effects , Fluorescent Antibody Technique , Humans , Microscopy, Confocal , Pemphigoid, Bullous/etiology , SARS-CoV-2 , Spike Glycoprotein, Coronavirus , T-Lymphocytes , Vaccination
5.
Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.
Tomayko, Mary M; Damsky, William; Fathy, Ramie; McMahon, Devon E; Turner, Noel; Valentin, Monica N; Rallis, Tena; Aivaz, Ohara; Fox, Lindy P; Freeman, Esther E.
J Allergy Clin Immunol ; 148(3): 750-751, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1313184

Subject(s)
Blister/diagnosis , Blister/etiology , COVID-19 Vaccines/adverse effects , Pemphigoid, Bullous/diagnosis , Pemphigoid, Bullous/etiology , Blister/therapy , COVID-19 Vaccines/administration & dosage , Disease Management , Disease Susceptibility , Humans , Pemphigoid, Bullous/therapy , Vaccination/adverse effects , Vaccination/methods
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL